+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antibody Production Market by Product (Consumables, Instruments, Software), Antibody Type (Monoclonal, Polyclonal), Production Process, Class, Purification Method, Application, End-User - Global Forecast 2025-2030- Product Image
Antibody Production Market by Product (Consumables, Instruments, Software), Antibody Type (Monoclonal, Polyclonal), Production Process, Class, Purification Method, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Antibody Production Market by Product (Consumables, Instruments, Software), Antibody Type (Monoclonal, Polyclonal), Production Process, Class, Purification Method, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888112
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Explore the antibody production market’s evolving landscape as precision, innovation, and adaptability become central to global biopharmaceutical growth. Gain actionable clarity on competitive dynamics and new operational priorities—from automation to regulatory shifts—enabling proactive strategic planning for senior leaders.

Market Snapshot: Antibody Production Market Growth and Outlook

The antibody production market grew from USD 20.16 billion in 2024 to USD 22.62 billion in 2025. This sector is on track for robust expansion, maintaining a CAGR of 12.45% and projected to reach USD 40.77 billion by 2030. Market drivers include advancements in bioprocessing platforms, heightened demands in therapeutics and diagnostics, and increasing regulatory and supply chain complexity across global regions.

Scope & Segmentation

  • Products: Consumables such as buffers, reagents, chromatography resins, and media; Instruments like bioreactors, chromatography systems, and filtration systems; Software solutions for process scheduling and analytics.
  • Antibody Types: Monoclonal and polyclonal platforms influence development strategies and production models.
  • Production Processes: Downstream and upstream processing each bring unique optimization, media adjustment, and quality control challenges.
  • Classes: Includes IgA, IgD, IgE, IgG, and IgM, each requiring tailored purification protocols and approaches.
  • Purification Methods: Techniques incorporate immobilized metal chelate chromatography, ion exchange chromatography, and size exclusion chromatography for high-purity outputs.
  • Applications: Diagnostics, research, and therapeutics, supporting areas such as autoimmune diseases, cancer therapy, infectious diseases, and neurological disorders.
  • End-Users: Academic and research institutes, biotechnology companies, contract research organizations, and pharmaceutical companies are the main market drivers.
  • Regions: Americas, Europe Middle East & Africa, and Asia-Pacific, each with unique regulatory environments and capacities.
  • Leading Companies: Includes AbbVie Inc., Amgen Inc., AstraZeneca PLC, Biogen Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., and others in biomanufacturing, instruments, and technology.

Key Takeaways for Senior Decision-Makers

  • Technological innovation is reshaping workflows, integrating automation, and digital analytics to minimize human error and accelerate timelines throughout antibody production.
  • Changing regional supply networks and evolving regulatory guidance highlight the critical need for agile procurement and compliance frameworks.
  • Segment-specific production strategies—spanning monoclonal versus polyclonal antibodies and multiple classes—drive investment in specialized equipment and tailored purification technology.
  • Process intensification and sustainability initiatives are increasingly factored into operational planning and stakeholder expectations.
  • Collaborative partnerships, joint ventures, and technology transfer agreements are strengthening market resilience and supply chain agility.
  • Cloud-based management systems unify process data and support continuous improvement, while machine learning models help refine batch production outcomes.

Tariff Impact: Strategic Response to U.S. 2025 Tariff Measures

Recent U.S. tariff measures have triggered industry-wide adjustments, with costs from import duties on raw materials rippling across the value chain. Key players are responding by diversifying supplier partnerships, innovating sourcing strategies, and fostering collaborative agreements. These proactive approaches are designed to stabilize procurement budgets and minimize risk from currency volatility and logistics disruptions.

Methodology & Data Sources

This report combines first-hand interviews with C-level leaders, process engineers, and QA specialists from prominent biopharmaceutical companies with a thorough review of peer-reviewed journals, regulatory filings, and industry white papers. Findings are validated through expert review and cross-checked against recognized secondary resources to ensure accuracy and practical relevance.

Why This Report Matters: Outcomes for Senior Leaders

  • Enables informed strategic planning by providing segmented, actionable intelligence on product categories, technologies, and applications within antibody production.
  • Equips readers to anticipate disruptions and optimize procurement, risk management, and compliance responses in a fast-evolving regulatory and supply environment.

Conclusion

This report offers a structured, impartial view of the antibody production market. It is designed to support executive-level decisions by clarifying technology adoption, supply chain trends, and operational excellence benchmarks essential for growth in biopharmaceutical manufacturing.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of single-use bioreactor systems for scalable monoclonal antibody manufacturing with reduced contamination risk
5.2. Adoption of continuous downstream processing for accelerated antibody purification and higher throughput yields
5.3. Implementation of AI-driven cell line development to optimize antibody expression and stability profiles
5.4. Transition toward glycoengineered antibodies to improve therapeutic efficacy and minimize immunogenic responses
5.5. Expansion of contract development and manufacturing organization partnerships for cost-effective antibody production
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antibody Production Market, by Product
8.1. Introduction
8.2. Consumables
8.2.1. Buffers & Reagents
8.2.2. Chromatography Resins
8.2.3. Media
8.3. Instruments
8.3.1. Bioreactors
8.3.2. Chromatography Systems
8.3.3. Filtration Systems
8.4. Software
9. Antibody Production Market, by Antibody Type
9.1. Introduction
9.2. Monoclonal
9.3. Polyclonal
10. Antibody Production Market, by Production Process
10.1. Introduction
10.2. Downstream Processing
10.3. Upstream Processing
11. Antibody Production Market, by Class
11.1. Introduction
11.2. IgA
11.3. IgD
11.4. IgE
11.5. IgG
11.6. IgM
12. Antibody Production Market, by Purification Method
12.1. Introduction
12.2. Immobilized Metal Chelate Chromatography
12.3. Ion Exchange Chromatography
12.4. Size Exclusion Chromatography
13. Antibody Production Market, by Application
13.1. Introduction
13.2. Diagnostics
13.3. Research
13.4. Therapeutics
13.4.1. Autoimmune Diseases
13.4.2. Cancer Therapy
13.4.3. Infectious Diseases
13.4.4. Neurological Disorders
14. Antibody Production Market, by End-User
14.1. Introduction
14.2. Academic & Research Institutes
14.3. Biotechnology Companies
14.4. Contract Research Organizations
14.5. Pharmaceutical Companies
15. Americas Antibody Production Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Antibody Production Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Antibody Production Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. AbbVie Inc.
18.3.2. Amgen Inc.
18.3.3. AstraZeneca PLC
18.3.4. Biogen Inc.
18.3.5. Bristol-Myers Squibb Company
18.3.6. Cell Signaling Technology, Inc.
18.3.7. Eppendorf AG
18.3.8. F. Hoffmann-La Roche Ltd.
18.3.9. Fibercell Systems Inc
18.3.10. GE HealthCare Technologies Inc.
18.3.11. Genmab A/S
18.3.12. GenScript Biotech Corporation
18.3.13. Gilead Sciences, Inc.
18.3.14. INTEGRA Biosciences AG
18.3.15. Merck KGaA
18.3.16. Novartis AG
18.3.17. Novo Nordisk A/S
18.3.18. Pall Corporation
18.3.19. Pfizer Inc.
18.3.20. ProteoGenix
18.3.21. Sanofi S.A.
18.3.22. Sartorius AG
18.3.23. Teva Pharmaceutical Industries Ltd.
18.3.24. The Antibody Company
18.3.25. Thermo Fisher Scientific Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. ANTIBODY PRODUCTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ANTIBODY PRODUCTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ANTIBODY PRODUCTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. ANTIBODY PRODUCTION MARKET: RESEARCHAI
FIGURE 30. ANTIBODY PRODUCTION MARKET: RESEARCHSTATISTICS
FIGURE 31. ANTIBODY PRODUCTION MARKET: RESEARCHCONTACTS
FIGURE 32. ANTIBODY PRODUCTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIBODY PRODUCTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY BUFFERS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY BUFFERS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CHROMATOGRAPHY RESINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CHROMATOGRAPHY RESINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY MEDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY MEDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY MONOCLONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY MONOCLONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY POLYCLONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY POLYCLONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGD, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGD, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGG, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGG, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGM, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IGM, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IMMOBILIZED METAL CHELATE CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY IMMOBILIZED METAL CHELATE CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY ION EXCHANGE CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY ION EXCHANGE CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY SIZE EXCLUSION CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY SIZE EXCLUSION CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CANCER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CANCER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ANTIBODY PRODUCTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 138. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 139. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 140. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 141. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 142. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 143. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 146. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 147. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 148. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 149. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 150. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 151. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 154. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 155. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 260. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 261. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 262. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 263. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 264. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 265. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 267. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 268. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 269. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 270. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 272. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 273. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 279. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 280. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 281. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 282. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 283. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 284. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 285. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 286. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 287. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 288. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 289. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 290. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 291. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 292. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 293. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 296. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 319. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 320. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 321. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 322. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 323. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 324. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 325. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2018-2024 (USD MILLION)
TABLE 326. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY ANTIBODY TYPE, 2025-2030 (USD MILLION)
TABLE 327. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 328. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 329. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2018-2024 (USD MILLION)
TABLE 330. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY CLASS, 2025-2030 (USD MILLION)
TABLE 331. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2018-2024 (USD MILLION)
TABLE 332. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY PURIFICATION METHOD, 2025-2030 (USD MILLION)
TABLE 333. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 336. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 337. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 338. ITALY ANTIBODY PRODUCTION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 339. SPAIN ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 340. SPAIN ANTIBODY PRODUCTION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 341. SPAIN ANTIBODY PRODUCTI

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Antibody Production market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Cell Signaling Technology, Inc.
  • Eppendorf AG
  • F. Hoffmann-La Roche Ltd.
  • Fibercell Systems Inc
  • GE HealthCare Technologies Inc.
  • Genmab A/S
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • INTEGRA Biosciences AG
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Pall Corporation
  • Pfizer Inc.
  • ProteoGenix
  • Sanofi S.A.
  • Sartorius AG
  • Teva Pharmaceutical Industries Ltd.
  • The Antibody Company
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 40.77 Billion
Compound Annual Growth Rate12.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Custom Polyclonal Antibody Production Service Market by Product Type, Application, End User, Purification Technique, Technology - Global Forecast 2025-2030 - Product Image

Custom Polyclonal Antibody Production Service Market by Product Type, Application, End User, Purification Technique, Technology - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Mammalian Polyclonal IgG Antibody Market by Animal Source (Donkey, Goat, Mouse), Application (Diagnostic, Research, Therapeutic), Purification Method, End User, Formulation, Distribution Channel - Global Forecast 2025-2030 - Product Image

Mammalian Polyclonal IgG Antibody Market by Animal Source (Donkey, Goat, Mouse), Application (Diagnostic, Research, Therapeutic), Purification Method, End User, Formulation, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Polyclonal Antibodies - Global Strategic Business Report - Product Image

Polyclonal Antibodies - Global Strategic Business Report

  • Report
  • 462 Pages
  • Global
From
Bispecific Antibody Therapeutics Contract Manufacturing - Global Strategic Business Report - Product Image

Bispecific Antibody Therapeutics Contract Manufacturing - Global Strategic Business Report

  • Report
  • 382 Pages
  • Global
From
Antibody Discovery - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Antibody Discovery - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From

About the Antibody Production Market

The Antibody Production market is a segment of the biopharmaceutical industry that focuses on the production of antibodies for therapeutic and diagnostic purposes. Antibodies are proteins that are produced by the immune system to recognize and bind to specific antigens, such as bacteria and viruses. Antibody production involves the use of recombinant DNA technology to produce large quantities of antibodies for use in research, diagnostics, and therapeutics. The market is driven by the increasing demand for biopharmaceuticals, as well as the development of new technologies and techniques for producing antibodies. The Antibody Production market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.